Ho Maykin

CIK 00016463955 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001646395

Recent Transactions

50 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-20+2,120→ 17,032 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-20−2,120→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-18+2,816→ 2,816 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-06-18+15,768→ 15,768 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2025-06-04+120,000→ 120,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+95,586→ 95,586 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+80,000→ 80,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+27,802→ 27,802 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−28,571→ 0 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−27,802→ 0 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−95,586→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+28,571→ 28,571 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-05-20+6,650→ 28,010 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−95,586→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+95,586→ 95,586 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−28,571→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+27,802→ 27,802 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+28,571→ 28,571 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−27,802→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2024-06-13+28,571→ 28,571 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-06-13+20,100→ 20,100 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+3,388→ 14,912 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−3,388→ 0 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2024-06-05+70,000→ 70,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 21,360 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2023-09-14+27,802→ 27,802 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2023-06-21−4,975→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-21+4,975→ 11,524 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-06-13+18,958→ 18,958 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-06-13+3,388→ 3,388 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-08$16.79/sh−2,295→ 37,726 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-08$17.68/sh−6,225→ 31,501 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-06-07+8,289→ 40,021 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-06-07+12,666→ 12,666 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-05-23+4,190→ 16,640 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-06-21+29,307→ 29,307 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-06-21+4,975→ 4,975 total
Award
FIBROGEN INC$FGEN
Common Stock
2022-06-16+15,777→ 31,732 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2022-06-16+25,684→ 25,684 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-05-24+4,980→ 12,450 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-05-20−1,585→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-05-20+1,585→ 6,549 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-05-28+1,686→ 4,964 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-05-28−1,686→ 0 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-05-26+7,800→ 7,800 total
Award
FIBROGEN INC$FGEN
Common Stock
2021-05-26+4,700→ 15,955 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-05-25+5,120→ 7,470 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2021-05-20+8,888→ 8,888 total

Companies

Recent Filings

Address

C/O NEUMORA THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472

View on SEC.gov